Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn’s disease of inflammatory type

Yutaka Nagata, Motohiro Esaki, Tomohiko Moriyama, Atsushi Hirano, Junji Umeno, Yuji Maehata, Takehiro Torisu, Takayuki Matsumoto, Takanari Kitazono

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn’s disease of inflammatory type'. Together they form a unique fingerprint.

Medicine and Dentistry